AGXT Gene Mutations and Prevalence of Primary Hyperoxaluria Type 1 in Moroccan Population
- PMID: 26383609
- DOI: 10.1089/gtmb.2015.0136
AGXT Gene Mutations and Prevalence of Primary Hyperoxaluria Type 1 in Moroccan Population
Abstract
Introduction: Primary hyperoxaluria type 1 (PH1) is an autosomal recessive disorder caused by deficiency of alanine glyoxylate aminotransferase, due to a defect in the AGXT gene. Several mutations in this gene have been reported and some of them have been observed in multiple populations. The aim of our study was to analyze the mutations causing PH1 in the Moroccan population and to estimate its prevalence in Morocco.
Methods: Molecular studies of 29 unrelated Moroccan patients with PH were performed by direct sequencing of all exons of the AGXT gene. In addition, to estimate the prevalence of PH1, we screened for the recurrent p.Ile244Thr mutation in 250 unrelated Moroccan newborns using real-time polymerase chain reaction.
Results: Four pathogenic mutations were detected in 25 unrelated patients. The c.731T>C (p.Ile244Thr) was the most frequent mutation with a frequency of 84%. The other three mutations were c.33delC, c.976delG, and c.331C>T. The prevalence of the PH1 mutation among Moroccans was then estimated to range from 1/7267 to 1/6264.
Conclusion: PH1 is one of the most prevalent genetic diseases in the Moroccan population and is probably underdiagnosed. Front line genetic testing for PH1 in Morocco should be initiated using an assay for the recurrent p.Ile244Thr mutation. This strategy would provide a useful tool for precocious diagnosis of presymptomatic individuals and to prevent their rapid progression to renal failure.
Similar articles
-
Mutational Analysis of Agxt in Tunisian Population with Primary Hyperoxaluria Type 1.Ann Hum Genet. 2017 Jan;81(1):1-10. doi: 10.1111/ahg.12178. Epub 2016 Dec 9. Ann Hum Genet. 2017. PMID: 27935012
-
A double mutation in AGXT gene in families with primary hyperoxaluria type 1.Gene. 2013 Dec 1;531(2):451-6. doi: 10.1016/j.gene.2013.08.083. Epub 2013 Sep 5. Gene. 2013. PMID: 24012869
-
Mutation spectrum of primary hyperoxaluria type 1 in Tunisia: implication for diagnosis in North Africa.Gene. 2013 Sep 15;527(1):316-20. doi: 10.1016/j.gene.2013.06.023. Epub 2013 Jun 25. Gene. 2013. PMID: 23810941
-
Primary hyperoxaluria type 1: update and additional mutation analysis of the AGXT gene.Hum Mutat. 2009 Jun;30(6):910-7. doi: 10.1002/humu.21021. Hum Mutat. 2009. PMID: 19479957 Review.
-
[From gene to disease; primary hyperoxaluria type I caused by mutations in the AGXT gene].Ned Tijdschr Geneeskd. 2006 Jul 29;150(30):1669-72. Ned Tijdschr Geneeskd. 2006. PMID: 16922352 Review. Dutch.
Cited by
-
Primary hyperoxaluria type 1: pathophysiology and genetics.Clin Kidney J. 2022 May 17;15(Suppl 1):i4-i8. doi: 10.1093/ckj/sfab217. eCollection 2022 May. Clin Kidney J. 2022. PMID: 35592619 Free PMC article. Review.
-
Two novel AGXT mutations identified in primary hyperoxaluria type-1 and distinct morphological and structural difference in kidney stones.Sci Rep. 2016 Sep 20;6:33652. doi: 10.1038/srep33652. Sci Rep. 2016. PMID: 27644547 Free PMC article.
-
Primary hyperoxaluria type 1 in developing countries: novel challenges in a new therapeutic era.Clin Kidney J. 2022 May 17;15(Suppl 1):i33-i36. doi: 10.1093/ckj/sfab203. eCollection 2022 May. Clin Kidney J. 2022. PMID: 35592622 Free PMC article. Review.
-
An Investigational RNAi Therapeutic Targeting Glycolate Oxidase Reduces Oxalate Production in Models of Primary Hyperoxaluria.J Am Soc Nephrol. 2017 Feb;28(2):494-503. doi: 10.1681/ASN.2016030338. Epub 2016 Jul 18. J Am Soc Nephrol. 2017. PMID: 27432743 Free PMC article.
-
Primary hyperoxaluria type 1: Clinical, genetic, and evolutionary characteristics in Tunisian children.Tunis Med. 2023 Jul 5;101(7):626-630. Tunis Med. 2023. PMID: 38445424 Free PMC article. French.
MeSH terms
Substances
Supplementary concepts
LinkOut - more resources
Full Text Sources